Published in ACS Nano on August 17, 2011
Engineering metallic nanostructures for plasmonics and nanophotonics. Rep Prog Phys (2012) 1.29
Molecular plasmonics for biology and nanomedicine. Nanomedicine (Lond) (2012) 1.01
The neoglycolipid (NGL)-based oligosaccharide microarray system poised to decipher the meta-glycome. Curr Opin Chem Biol (2014) 1.00
Nanohole-based surface plasmon resonance instruments with improved spectral resolution quantify a broad range of antibody-ligand binding kinetics. Anal Chem (2012) 0.96
Nanopore-induced spontaneous concentration for optofluidic sensing and particle assembly. Anal Chem (2012) 0.85
Real-time full-spectral imaging and affinity measurements from 50 microfluidic channels using nanohole surface plasmon resonance. Lab Chip (2012) 0.84
High-density arrays of submicron spherical supported lipid bilayers. Anal Chem (2012) 0.82
Promises and Challenges of Nanoplasmonic Devices for Refractometric Biosensing. Nanophotonics (2013) 0.82
Nanohole Array-Directed Trapping of Mammalian Mitochondria Enabling Single Organelle Analysis. Anal Chem (2015) 0.77
Atomic layer deposition (ALD): A versatile technique for plasmonics and nanobiotechnology. J Mater Res (2012) 0.76
Nanofabrication for the analysis and manipulation of membranes. Ann Biomed Eng (2011) 0.76
Study of flow rate induced measurement error in flow-through nano-hole plasmonic sensor. Biomicrofluidics (2015) 0.75
Formation of biomembrane microarrays with a squeegee-based assembly method. J Vis Exp (2014) 0.75
Probing the Interaction of Dielectric Nanoparticles with Supported Lipid Membrane Coatings on Nanoplasmonic Arrays. Sensors (Basel) (2017) 0.75
Lipid rafts and signal transduction. Nat Rev Mol Cell Biol (2000) 25.87
Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med (1998) 25.41
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics. Biophys J (1976) 25.12
Lipid rafts as a membrane-organizing principle. Science (2010) 13.48
Printing proteins as microarrays for high-throughput function determination. Science (2000) 10.77
A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature (2005) 5.75
Myelination in rat brain: method of myelin isolation. J Neurochem (1973) 4.01
Self-assembling protein microarrays. Science (2004) 3.37
Micropatterning fluid lipid bilayers on solid supports. Science (1997) 3.11
Phase separation of lipid membranes analyzed with high-resolution secondary ion mass spectrometry. Science (2006) 3.07
Optical biosensors in drug discovery. Nat Rev Drug Discov (2002) 2.89
Micropattern formation in supported lipid membranes. Acc Chem Res (2002) 2.72
Surface plasmon sensor based on the enhanced light transmission through arrays of nanoholes in gold films. Langmuir (2004) 2.46
Surface specific kinetics of lipid vesicle adsorption measured with a quartz crystal microbalance. Biophys J (1998) 2.43
Architecture and function of membrane proteins in planar supported bilayers: a study with photosynthetic reaction centers. Biochemistry (1996) 2.16
Clathrate nanostructures for mass spectrometry. Nature (2007) 2.10
Desorption-ionization mass spectrometry on porous silicon. Nature (1999) 2.09
Protein microarrays: prospects and problems. Chem Biol (2001) 2.05
Micropatterned immobilization of a G protein-coupled receptor and direct detection of G protein activation. Nat Biotechnol (1999) 2.04
Localized surface plasmon resonance sensing of lipid-membrane-mediated biorecognition events. J Am Chem Soc (2005) 1.89
DNA biosensors and microarrays. Chem Rev (2007) 1.80
Co-culture of human embryonic stem cells with murine embryonic fibroblasts on microwell-patterned substrates. Biomaterials (2006) 1.79
Nanoparticle printing with single-particle resolution. Nat Nanotechnol (2007) 1.76
Molecular imaging by mass spectrometry--looking beyond classical histology. Nat Rev Cancer (2010) 1.72
Emerging tools for real-time label-free detection of interactions on functional protein microarrays. FEBS J (2005) 1.70
Quantitative multispectral biosensing and 1D imaging using quasi-3D plasmonic crystals. Proc Natl Acad Sci U S A (2006) 1.59
Carbohydrate microarrays - a new set of technologies at the frontiers of glycomics. Curr Opin Struct Biol (2003) 1.58
High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research. Trends Biotechnol (2009) 1.56
Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci U S A (2000) 1.46
Advances in membrane receptor screening and analysis. J Mol Recognit (2004) 1.45
Parallel, quantitative measurement of protein binding to a 120-element double-stranded DNA array in real time using surface plasmon resonance microscopy. Anal Chem (2004) 1.39
Self-assembled microarrays of attoliter molecular vessels. Angew Chem Int Ed Engl (2003) 1.36
Surface plasmon resonance imaging as a tool to monitor biomolecular interactions in an array based format. Appl Spectrosc (2003) 1.35
Molecular imaging and depth profiling by mass spectrometry--SIMS, MALDI or DESI? Analyst (2011) 1.34
Metallic nanohole arrays on fluoropolymer substrates as small label-free real-time bioprobes. Nano Lett (2008) 1.33
Nanoholes as nanochannels: flow-through plasmonic sensing. Anal Chem (2009) 1.33
Membrane protein microarrays. J Am Chem Soc (2002) 1.32
Imaging of membrane lipids in single cells by imprint-imaging time-of-flight secondary ion mass spectrometry. Anal Chem (2003) 1.23
Direct photochemical patterning and refunctionalization of supported phospholipid bilayers. J Am Chem Soc (2004) 1.22
Secondary ion MS imaging of lipids in picoliter vials with a buckminsterfullerene ion source. Anal Chem (2005) 1.19
Liposome and lipid bilayer arrays towards biosensing applications. Small (2010) 1.17
Formation of supported bilayers on silica substrates. Langmuir (2009) 1.14
Membrane protein biosensing with plasmonic nanopore arrays and pore-spanning lipid membranes. Chem Sci (2010) 1.14
Simultaneously monitoring gene expression kinetics and genetic noise in single cells by optical well arrays. Anal Chem (2004) 1.11
Atomic layer deposition of dielectric overlayers for enhancing the optical properties and chemical stability of plasmonic nanoholes. ACS Nano (2010) 1.09
Enhanced optical transmission mediated by localized plasmons in anisotropic, three-dimensional nanohole arrays. Nano Lett (2010) 1.06
Plasmonic nanoholes in a multichannel microarray format for parallel kinetic assays and differential sensing. Anal Chem (2009) 1.04
Living bacterial cell array for genotoxin monitoring. Anal Chem (2004) 1.02
Sub-100 nm patterning of supported bilayers by nanoshaving lithography. J Am Chem Soc (2008) 0.98
Cell membranes suspended across nanoaperture arrays. Langmuir (2006) 0.92
Multiplexing ligand-receptor binding measurements by chemically patterning microfluidic channels. Anal Chem (2008) 0.92
Formation and characterization of fluid lipid bilayers on alumina. Langmuir (2008) 0.87
Using the angle-dependent resonances of molded plasmonic crystals to improve the sensitivities of biosensors. Nano Lett (2010) 0.86
Selective deposition of native cell membranes on biocompatible micropatterns. J Am Chem Soc (2004) 0.85
Arraying of intact liposomes into chemically functionalized microwells. Langmuir (2006) 0.83
Optical properties of anisotropic core-shell pyramidal particles. J Phys Chem A (2009) 0.83
Vesicle adsorption and phospholipid bilayer formation on topographically and chemically nanostructured surfaces. J Phys Chem B (2010) 0.81
Generic surface modification strategy for sensing applications based on AuSiO2 nanostructures. Biointerphases (2007) 0.80
Multiplexed spectroscopic detections. Annu Rev Anal Chem (Palo Alto Calif) (2008) 0.80
Creation of a functional heterogeneous vesicle array via DNA controlled surface sorting onto a spotted microarray. Biointerphases (2006) 0.78
Controlled formation and mixing of two-dimensional fluids. Nano Lett (2007) 0.77
Platform for controlled supramolecular nanoassembly. Nano Lett (2009) 0.76
Microstructured liposome array. Bioconjug Chem (2006) 0.76
Ultrasmooth patterned metals for plasmonics and metamaterials. Science (2009) 3.43
White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab (2011) 2.68
Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet (2005) 2.68
Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol (2006) 2.67
Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation (2011) 2.52
Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol (2004) 2.37
Multiple sclerosis, brain radiotherapy, and risk of neurotoxicity: the Mayo Clinic experience. Int J Radiat Oncol Biol Phys (2006) 2.12
Signalling and crosstalk of Rho GTPases in mediating axon guidance. Nat Cell Biol (2003) 1.84
Chronic fine particulate matter exposure induces systemic vascular dysfunction via NADPH oxidase and TLR4 pathways. Circ Res (2011) 1.83
Retracted Cross-linking the B7 family molecule B7-DC directly activates immune functions of dendritic cells. J Exp Med (2002) 1.68
Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis. Arch Neurol (2010) 1.61
Beneficial plasma exchange response in central nervous system inflammatory demyelination. Arch Neurol (2011) 1.49
Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am J Physiol Heart Circ Physiol (2009) 1.44
The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40
Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol (2004) 1.36
A magneto-DNA nanoparticle system for rapid detection and phenotyping of bacteria. Nat Nanotechnol (2013) 1.35
Recent progress in SERS biosensing. Phys Chem Chem Phys (2011) 1.35
Template-stripped smooth Ag nanohole arrays with silica shells for surface plasmon resonance biosensing. ACS Nano (2011) 1.29
Engineering metallic nanostructures for plasmonics and nanophotonics. Rep Prog Phys (2012) 1.29
Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia. Blood (2005) 1.29
Exposure to ambient particulate matter induces a NASH-like phenotype and impairs hepatic glucose metabolism in an animal model. J Hepatol (2012) 1.28
Absence of perforin expression confers axonal protection despite demyelination. Neurobiol Dis (2006) 1.26
Retracted Immunotherapeutic potential of B7-DC (PD-L2) cross-linking antibody in conferring antitumor immunity. Cancer Res (2004) 1.26
Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur J Immunol (2003) 1.25
Vertically oriented sub-10-nm plasmonic nanogap arrays. Nano Lett (2010) 1.23
Direct inhibition of RNA polymerase II transcription by RECQL5. J Biol Chem (2009) 1.22
Ambient particulate air pollution induces oxidative stress and alterations of mitochondria and gene expression in brown and white adipose tissues. Part Fibre Toxicol (2011) 1.22
Atomic layer lithography of wafer-scale nanogap arrays for extreme confinement of electromagnetic waves. Nat Commun (2013) 1.21
Retracted Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells. J Immunol (2003) 1.21
Reduced metabolic insulin sensitivity following sub-acute exposures to low levels of ambient fine particulate matter air pollution. Sci Total Environ (2012) 1.19
Highly reproducible near-field optical imaging with sub-20-nm resolution based on template-stripped gold pyramids. ACS Nano (2012) 1.18
Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins. Biotechnol J (2009) 1.15
A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res (2007) 1.15
Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci (2003) 1.15
Seizures in patients with multiple sclerosis: epidemiology, pathophysiology and management. CNS Drugs (2009) 1.14
Membrane protein biosensing with plasmonic nanopore arrays and pore-spanning lipid membranes. Chem Sci (2010) 1.14
Ultrafast synaptic events in a chalcogenide memristor. Sci Rep (2013) 1.14
Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci (2003) 1.14
Three-dimensional plasmonic nanofocusing. Nano Lett (2010) 1.14
Single-crystalline silver films for plasmonics. Adv Mater (2012) 1.13
CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J Neuroimmunol (2007) 1.12
Efficient central nervous system remyelination requires T cells. Ann Neurol (2003) 1.11
Sub-micron resolution surface plasmon resonance imaging enabled by nanohole arrays with surrounding Bragg mirrors for enhanced sensitivity and isolation. Lab Chip (2008) 1.11
Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol (2005) 1.09
Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem (2002) 1.09
Retracted Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody. J Immunol (2004) 1.09
Atomic layer deposition of dielectric overlayers for enhancing the optical properties and chemical stability of plasmonic nanoholes. ACS Nano (2010) 1.09
Targeting cancer with a lupus autoantibody. Sci Transl Med (2012) 1.09
A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS. FASEB J (2004) 1.08
Neuron-binding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol (2004) 1.08
Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways. Vascul Pharmacol (2011) 1.07
Self-assembled plasmonic nanohole arrays. Langmuir (2009) 1.07
Acute hemorrhagic demyelination in a murine model of multiple sclerosis. J Neuroinflammation (2008) 1.07
Demyelinated axons and motor function are protected by genetic deletion of perforin in a mouse model of multiple sclerosis. J Neuropathol Exp Neurol (2009) 1.06
Kallikreins are associated with secondary progressive multiple sclerosis and promote neurodegeneration. Biol Chem (2008) 1.06
Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia (2002) 1.06
Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity. Leuk Res (2005) 1.05
Air pollution-mediated susceptibility to inflammation and insulin resistance: influence of CCR2 pathways in mice. Environ Health Perspect (2013) 1.05
HLA DR and DQ interaction in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in HLA class II transgenic mice. J Neuroimmunol (2005) 1.04
Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network. J Child Neurol (2012) 1.04
Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J (2002) 1.04
Plasmonic nanoholes in a multichannel microarray format for parallel kinetic assays and differential sensing. Anal Chem (2009) 1.04
Identification of T cell epitopes on human proteolipid protein and induction of experimental autoimmune encephalomyelitis in HLA class II-transgenic mice. Eur J Immunol (2004) 1.04
Clinical and molecular epidemiology of norovirus infection in childhood diarrhea in China. J Med Virol (2011) 1.04
Disrupted spatial memory is a consequence of picornavirus infection. Neurobiol Dis (2006) 1.04
Enzymatic properties of rat myelencephalon-specific protease. Biochemistry (2002) 1.03
Two compounds from allelopathic rice accession and their inhibitory activity on weeds and fungal pathogens. Phytochemistry (2004) 1.02
The SET2-RPB1 interaction domain of human RECQ5 is important for transcription-associated genome stability. Mol Cell Biol (2011) 1.02
CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. Blood (2012) 1.02
Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis. Mult Scler (2012) 1.01
Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease. FASEB J (2004) 1.01
Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome. Arch Neurol (2006) 1.01
CD8+ T cells cause disability and axon loss in a mouse model of multiple sclerosis. PLoS One (2010) 0.99
Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord (2004) 0.99
Antiapoptotic signaling by a remyelination-promoting human antimyelin antibody. Neurobiol Dis (2004) 0.99
Laser-illuminated nanohole arrays for multiplex plasmonic microarray sensing. Opt Express (2008) 0.98
Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord. Ann Neurol (2009) 0.98
Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx (2005) 0.97
Nanoscale fluorescence lifetime imaging of an optical antenna with a single diamond NV center. Nano Lett (2013) 0.96
Nanohole-based surface plasmon resonance instruments with improved spectral resolution quantify a broad range of antibody-ligand binding kinetics. Anal Chem (2012) 0.96
HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J Immunol (2008) 0.95
Dielectrophoresis-enhanced plasmonic sensing with gold nanohole arrays. Nano Lett (2014) 0.94
Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropathol Exp Neurol (2005) 0.94
A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination. PLoS One (2011) 0.94
MRI in rodent models of brain disorders. Neurotherapeutics (2011) 0.94